{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:30:43Z","timestamp":1792031443099,"version":"4.4.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070443"],"award-info":[{"award-number":["82070443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974041"],"award-info":[{"award-number":["81974041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470497"],"award-info":[{"award-number":["81470497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670414"],"award-info":[{"award-number":["81670414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130009"],"award-info":[{"award-number":["82130009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91949128"],"award-info":[{"award-number":["91949128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270447"],"award-info":[{"award-number":["82270447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873485"],"award-info":[{"award-number":["81873485"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.atherosclerosis.2024.117480","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T08:09:36Z","timestamp":1707466176000},"page":"117480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Coptisine inhibits neointimal hyperplasia through attenuating Pak1\/Pak2 signaling in vascular smooth muscle cells without retardation of re-endothelialization"],"prefix":"10.1016","volume":"391","author":[{"given":"Yuhan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueze","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesheng","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6597-2267","authenticated-orcid":false,"given":"Yuepeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.117480_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.carrev.2015.01.002","article-title":"Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass gRafting in patients with multivessel coronary artery disease: meta-analysis of six randomized controlled trials","volume":"16","author":"Fanari","year":"2015","journal-title":"Cardiovasc. Revascularization Med."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"63","author":"Palmerini","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib3","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.biotechadv.2018.04.002","article-title":"Vascular smooth muscle cell proliferation as a therapeutic target. Part 2: natural products inhibiting proliferation","volume":"36","author":"Uhrin","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamacardio.2019.4101","article-title":"Time-varying outcomes with the absorb bioresorbable vascular scaffold during 5-year follow-up: a systematic meta-analysis and individual patient data pooled study","volume":"4","author":"Stone","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11239-014-1052-y","article-title":"Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"38","author":"De Luca","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2007.04.031","article-title":"Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives","volume":"50","author":"Jaffe","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrcardio.2015.164","article-title":"Pathophysiology of native coronary, vein gRaft, and in-stent atherosclerosis","volume":"13","author":"Yahagi","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib8","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2011.10.909","article-title":"In-stent neoatherosclerosis: a final common pathway of late stent failure","volume":"59","author":"Park","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib9","doi-asserted-by":"crossref","first-page":"7946","DOI":"10.1111\/jcmm.14725","article-title":"Coptisine from Coptis chinensis exerts diverse beneficial properties: a concise review","volume":"23","author":"Wu","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2016.03.037","article-title":"Coptisine from Coptis chinensis inhibits production of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 murine macrophage cells","volume":"780","author":"Wu","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173912","article-title":"Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response","volume":"896","author":"Wang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2013.10.003","article-title":"Coptisine protects rat heart against myocardial ischemia\/reperfusion injury by suppressing myocardial apoptosis and inflammation","volume":"231","author":"Guo","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopha.2017.07.002","article-title":"The protective effect of coptisine on experimental atherosclerosis ApoE-\/- mice is mediated by MAPK\/NF-\u03baB-dependent pathway","volume":"93","author":"Feng","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172523","article-title":"Glucose consumption assay discovers coptisine with beneficial effect on diabetic mice","volume":"859","author":"Shi","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ddr.21302","article-title":"Antihyperglycemia and antihyperlipidemia effect of protoberberine alkaloids from rhizoma Coptidis in HepG2 cell and diabetic KK-ay mice","volume":"77","author":"Ma","year":"2016","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.phymed.2017.12.027","article-title":"Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K\/Akt and mitochondrial-associated apoptotic pathway","volume":"48","author":"Han","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cbi.2018.11.005","article-title":"8-Cetylcoptisine, a new coptisine derivative, induces mitochondria-dependent apoptosis and G0\/G1 cell cycle arrest in human A549 cells","volume":"299","author":"Han","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fphar.2016.00362","article-title":"Rhizoma Coptidis: a potential cardiovascular protective agent","volume":"7","author":"Tan","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.atherosclerosis.2012.01.046","article-title":"Coptisine exert cardioprotective effect through anti-oxidative and inhibition of RhoA\/Rho kinase pathway on isoproterenol-induced myocardial infarction in rats","volume":"222","author":"Gong","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2020.101392","article-title":"Coptisine alleviates ischemia\/reperfusion-induced myocardial damage by regulating apoptosis-related proteins","volume":"66","author":"Sun","year":"2020","journal-title":"Tissue Cell"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.phymed.2005.02.001","article-title":"Selective inhibition of vascular smooth muscle cell proliferation by coptisine isolated from Coptis rhizoma, one of the crude drugs composing Kampo medicines Unsei-in","volume":"13","author":"Tanabe","year":"2006","journal-title":"Phytomedicine"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib22","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.bcp.2005.07.010","article-title":"Double blockade of cell cycle progression by coptisine in vascular smooth muscle cells","volume":"70","author":"Tanabe","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/np100645d","article-title":"Differential gene expression in rat vascular smooth muscle cells following treatment with coptisine exerts a selective antiproliferative effect","volume":"74","author":"Suzuki","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1248\/bpb.33.677","article-title":"Selective regulation of multidrug resistance protein in vascular smooth muscle cells by the isoquinoline alkaloid coptisine","volume":"33","author":"Suzuki","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12906-015-0632-5","article-title":"Simultaneous quantification and antiatherosclerosis effect of the traditional Korean medicine, Hwangryunhaedok-tang","volume":"15","author":"Seo","year":"2015","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/srep00090","article-title":"Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database","volume":"1","author":"Khoury","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.gene.2016.12.014","article-title":"Structure, biochemistry, and biology of Pak kinases","volume":"605","author":"Kumar","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib28","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0092-8674(05)80018-2","article-title":"The small GTP-bidning proteins Rac1 and Cdc42 regulate the activity of the JNK\/SAPK signaling pathway","volume":"81","author":"Coso","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.RES.0000258492.96097.47","article-title":"Mechanisms of vascular smooth muscle cell migration","volume":"100","author":"Gerthoffer","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib30","doi-asserted-by":"crossref","first-page":"E707","DOI":"10.1152\/ajpendo.00506.2013","article-title":"p21-Activated protein kinases and their emerging roles in glucose homeostasis","volume":"306","author":"Chiang","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4161\/cl.21882","article-title":"Pak signaling in cancer","volume":"2","author":"Ye","year":"2012","journal-title":"Cell. Logist."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib32","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1038\/onc.2009.119","article-title":"Pak signaling in oncogenesis","volume":"28","author":"Molli","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib33","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1074\/jbc.274.12.8022","article-title":"Multisite autophosphorylation of p21-activated protein kinase g-pak as a function of activation","volume":"274","author":"Gatti","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib34","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1074\/jbc.M309937200","article-title":"p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells","volume":"279","author":"Balasenthil","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib35","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1158\/1078-0432.CCR-11-1952","article-title":"Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations","volume":"18","author":"Eswaran","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-319-12114-7_5","article-title":"Tyrosyl phosphorylated serine-threonine kinase Pak1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion","volume":"846","author":"Hammer","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib37","doi-asserted-by":"crossref","first-page":"14173","DOI":"10.18632\/oncotarget.13309","article-title":"Wells. Deciphering the link between PI3K and Pak: an opportunity to target key pathways in pancreatic cancer?","volume":"8","author":"Thillai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.cell.2017.01.013","article-title":"Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic Ras","volume":"168","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib39","doi-asserted-by":"crossref","first-page":"24698","DOI":"10.1074\/jbc.M413374200","article-title":"p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association","volume":"280","author":"Jin","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117480_bib40","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.molcel.2022.03.026","article-title":"Lyso-PAF, a biologically inactive phospholipid, contributes to RAF1 activation","volume":"82","author":"Gao","year":"2022","journal-title":"Mol. Cell."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib41","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/onc.2011.515","article-title":"PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling","volume":"31","author":"Shrestha","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.200212141","article-title":"PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation","volume":"162","author":"Slack-Davis","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib43","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/onc.2011.515","article-title":"PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling","volume":"31","author":"Shrestha","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.200212141","article-title":"PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation","volume":"162","author":"Slack-Davis","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib45","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","article-title":"ERK signalling: a master regulator of cell behaviour, life and fate","volume":"21","author":"Lavoie","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib47","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1074\/jbc.M110.181529","article-title":"Activation loop phosphorylation of ERK3\/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3\/4-MAPK-activated protein kinase 5 signaling pathway","volume":"286","author":"D\u00e9l\u00e9ris","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib48","doi-asserted-by":"crossref","first-page":"12057","DOI":"10.1074\/jbc.271.20.12057","article-title":"Characterization of a protein kinase that phosphorylates serine 189 of the mitogen-activated protein kinase homolog ERK3","volume":"271","author":"Cheng","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib49","doi-asserted-by":"crossref","first-page":"C123","DOI":"10.1152\/ajpcell.2001.281.1.C123","article-title":"p21-activated kinase 1 participates in tracheal smooth muscle cell migration by signaling to p38 Mapk","volume":"281","author":"Dechert","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0092-8674(95)90411-5","article-title":"Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death","volume":"80","author":"Yang","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/MCB.20.2.453-461.2000","article-title":"p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis","volume":"20","author":"Sch\u00fcrmann","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027637","article-title":"p21-Activated kinase 1 (Pak1) phosphorylates BAD directly at serine 111 in vitro and indirectly through Raf-1 at serine 112","volume":"6","author":"Ye","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.109.143057","article-title":"p21-activated kinase 1 participates in vascular remodeling in vitro and in vivo","volume":"55","author":"Hinoki","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib54","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00023.2003","article-title":"Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase","volume":"83","author":"Somlyo","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib55","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/01.RES.0000126848.54740.4A","article-title":"Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration","volume":"94","author":"Weber","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib56","doi-asserted-by":"crossref","first-page":"C1286","DOI":"10.1152\/ajpcell.00448.2004","article-title":"Angiotensin II-induced activation of p21-activated kinase 1 requires Ca2+ and protein kinase C{delta} in vascular smooth muscle cells","volume":"289","author":"Woolfolk","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib57","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/CIRCRESAHA.109.196691","article-title":"A role for Gab1\/SHP2 in thrombin activation of PAK1: gene transfer of kinase-dead PAK1 inhibits injury-induced restenosis","volume":"104","author":"Wang","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/01.RES.88.2.202","article-title":"Crucial role of type-1, but not type-3, inositol 1,4,5-trisphosphate (IP3) receptors in IP3-induced Ca2+ release, capacitative Ca2+ entry, and proliferation of A7r5 vascular smooth muscle cells","volume":"88","author":"Wang","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCRESAHA.108.188524","article-title":"ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells","volume":"104","author":"Wang","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yjmcc.2023.07.008","article-title":"Novel signaling axis of FHOD1-RNF213-Col1\u03b1\/Col3\u03b1 in the pathogenesis of hypertension-induced tunica media thickening","volume":"182","author":"Chen","year":"2023","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/cvr\/cvn188","article-title":"Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo","volume":"80","author":"Bond","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib62","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3389\/fphar.2020.00929","article-title":"Coptisine alleviates pristane-induced lupus-like disease and associated kidney and cardiovascular complications in mice","volume":"11","author":"Yan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib63","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/HYPERTENSIONAHA.116.08662","article-title":"Crucial role of ang-II-stimulated up-regulation, and not ROCK1- but ROCK2-mediated activation, of FHOD3 in the pathogenesis of aortic banding-induced cardiac hypertrophy","volume":"69","author":"Zhou","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib64","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/emboj\/19.9.2008","article-title":"Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK","volume":"19","author":"del Pozo","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib65","doi-asserted-by":"crossref","first-page":"26741","DOI":"10.1074\/jbc.C100229200","article-title":"Platelet-derived growth factor requires epidermal growth factor receptor to activate p21-activated kinase family kinases","volume":"276","author":"He","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib66","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/ATVBAHA.112.300234","article-title":"Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells","volume":"33","author":"Wu","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib67","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0006-2952(03)00550-1","article-title":"Fangchinoline inhibits rat aortic vascular smooth muscle cell proliferation and cell cycle progression through inhibition of ERK1\/2 activation and c-fos expression","volume":"66","author":"Zhang","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib68","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bjp.0705126","article-title":"Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation","volume":"138","author":"Ferri","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib69","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1254\/jjp.60.397","article-title":"Antiproliferative effects of the traditional Chinese medicine Shimotsu-to, its component cnidium rhizoma and derived compounds on primary cultures of mouse aorta smooth muscle cells","volume":"60","author":"Kobayashi","year":"1992","journal-title":"Jpn J Pharmcol"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib70","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.toxlet.2014.02.021","article-title":"Unraveling the novel anti-osteosarcoma function of coptisine and its mechanisms","volume":"226","author":"Yu","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib71","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1248\/bpb.b15-00293","article-title":"Pharmacokinetics and brain distribution and metabolite identification of coptisine, a protoberberine alkaloid with therapeutic potential for CNS disorders, in rats","volume":"38","author":"Su","year":"2015","journal-title":"Biol. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117480_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3918","article-title":"Pharmacokinetics and tissue distribution of coptisine in rats after oral administration by liquid chromatography-mass spectrometry","volume":"31","author":"Yan","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib73","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.fitote.2016.02.001","article-title":"Research progress on berberine with a special focus on its oral bioavailability","volume":"109","author":"Liu","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib74","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1248\/bpb.b15-00293","article-title":"Pharmacokinetics and brain distribution and metabolite identification of coptisine, a protoberberine alkaloid with therapeutic potential for CNS disorders, in rats","volume":"38","author":"Su","year":"2015","journal-title":"Biol. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117480_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3918","article-title":"Pharmacokinetics and tissue distribution of coptisine in rats after oral administration by liquid chromatography-mass spectrometry","volume":"31","author":"Yan","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib76","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1021\/acs.jmedchem.5b00964","article-title":"Synthesis and structure-activity relationships of quaternary coptisine derivatives as potential anti-ulcerative colitis agents","volume":"58","author":"Zhang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib77","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2014.09.006","article-title":"Syntheses and structure-activity relationships in cytotoxicities of 13-substituted quaternary coptisine derivatives","volume":"86","author":"Zhang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib78","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.drudis.2020.03.008","article-title":"Chemical evolution for taming the 'pathogenic kinase' Pak1","volume":"25","author":"Maruta","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib79","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.cellsig.2014.04.020","article-title":"P21-activated kinase in inflammatory and cardiovascular disease","volume":"26","author":"Taglieri","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2261-12-55","article-title":"The role of p21-activated kinase in the initiation of atherosclerosis","volume":"12","author":"Jhaveri","year":"2012","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2172-10-15","article-title":"Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated kinase-1","volume":"10","author":"Zhou","year":"2009","journal-title":"BMC Immunol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib82","article-title":"Perspectives on the role of P21-activated kinase 1 (Pak1) in the intestinal anti-inflammatory and antitumor potential of artepillin C","volume":"17","author":"da Silva","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117480_bib83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/ATVBAHA.107.156794","article-title":"Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice","volume":"28","author":"Sommerville","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14786419.2023.2254454","article-title":"Natural Pak1 inhibitors: potent anti-inflammatory effectors for prevention of pulmonary fibrosis in COVID-19 therapy","author":"Arslan","year":"2023","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib85","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41564-018-0246-z","article-title":"Salmonella stimulates pro-inflammatory signalling through p21-activated kinases bypassing innate immune receptors","volume":"3","author":"Sun","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.atherosclerosis.2024.117480_bib86","doi-asserted-by":"crossref","first-page":"C898","DOI":"10.1152\/ajpcell.00095.2005","article-title":"Pak1 induces podosome formation in A7r5 vascular smooth muscle cells in a Pak-interacting exchange factor-dependent manner","volume":"289","author":"Webb","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T21:37:37Z","timestamp":1718746657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":86,"alternative-id":["S0021915024000406"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117480","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coptisine inhibits neointimal hyperplasia through attenuating Pak1\/Pak2 signaling in vascular smooth muscle cells without retardation of re-endothelialization","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117480"}}